BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15847790)

  • 1. [PET-FDG study in a patient with history of uterine leiomyosarcoma during menstruation and a false positive result].
    Villar Luque LM; Sau Llanas P; Cantero Sánchez M; Maldonado Taillefer M; Gómez AM
    Rev Esp Med Nucl; 2005; 24(3):205-6. PubMed ID: 15847790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
    Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
    Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography.
    Chander S; Meltzer CC; McCook BM
    Clin Nucl Med; 2002 Jan; 27(1):22-4. PubMed ID: 11805479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of uterine leiomyoma showing fludeoxyglucose uptake on F-18 fludeoxyglucose positron emission tomography/computed tomography.
    Park JH; Han JY; Hyun IY; Lee BI; Moon YS
    J Obstet Gynaecol Res; 2010 Dec; 36(6):1261-4. PubMed ID: 21083837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma.
    Yokoo S; Zeng F; Nogami M; Ueno YR; Murakami T
    Clin Nucl Med; 2022 Jun; 47(6):e452-e454. PubMed ID: 35353760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case report.
    Umesaki N; Tanaka T; Miyama M; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
    Clin Imaging; 2001; 25(3):203-5. PubMed ID: 11679229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign uterine uptake of FDG: a case report and review of literature.
    Vriens D; de Geus-Oei LF; Flucke UE; van der Kogel AJ; Oyen WJ; Vierhout ME; van der Meer JW
    Neth J Med; 2010 Sep; 68(9):379-80. PubMed ID: 20876921
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography and uterine leiomyomas.
    Lee WL; Yuan CC; Wang PH
    Gynecol Oncol; 2007 Dec; 107(3):593-4; author reply 594-5. PubMed ID: 17826823
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
    Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
    J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative [
    Lee JW; Park JY; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1309-1316. PubMed ID: 29492644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High 18F-FDG uptake for uterine smooth muscle tumor of uncertain malignant potential.
    Zhang R; Tian X; Qin L; Lu D; Shen J
    Clin Nucl Med; 2015 Apr; 40(4):349-51. PubMed ID: 25674868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas.
    Murakami M; Tsukada H; Shida M; Watanabe M; Maeda H; Koido S; Hirasawa T; Muramatsu T; Miyamoto T; Nasu S; Yasuda S; Kajiwara H; Yasuda M; Ide M
    Int J Gynecol Cancer; 2006; 16(2):854-60. PubMed ID: 16681773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intense uterine activity on whole body
    Cheng J; Ou X
    Hell J Nucl Med; 2020; 23(1):90-91. PubMed ID: 32222737
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
    Umesaki N; Tanaka T; Miyama M; Kawamura N; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
    Gynecol Oncol; 2001 Mar; 80(3):372-7. PubMed ID: 11263934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET appearance of a postpartum uterus.
    Lin E
    Clin Nucl Med; 2006 Mar; 31(3):159-60. PubMed ID: 16495738
    [No Abstract]   [Full Text] [Related]  

  • 16. A rare localization of a common disease: Primary uterine Non-Hodgkin lymphoma mimicking leiomyosarcoma.
    Goksel S; Karaman E; Karacin P; Ersöz Ş
    J Cancer Res Ther; 2022; 18(4):1205-1207. PubMed ID: 36149191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine leiomyosarcoma metastatic to thyroid shown by
    Gauthé M; Testart Dardel N; Nascimento C; Trassard M; Banal A; Alberini JL
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):113-115. PubMed ID: 27777040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 fluorodeoxyglucose uptake in leiomyomatous uterus.
    Shida M; Murakami M; Tsukada H; Ishiguro Y; Kikuchi K; Yamashita E; Kajiwara H; Yasuda M; Ide M
    Int J Gynecol Cancer; 2007; 17(1):285-90. PubMed ID: 17291269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfall of (18)F-FDG-PET imaging in oncology: uterine fibromyoma.
    Tripathi M; Khurana A; D'Souza MM; Sharma R
    Hell J Nucl Med; 2009; 12(2):175-6. PubMed ID: 19675878
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomographic-computed tomographic imaging of a uterine sarcoma.
    Cher S; Lay Ergun E
    Clin Nucl Med; 2003 May; 28(5):443-4. PubMed ID: 12702956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.